Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geovax Labs
(NQ:
GOVX
)
6.390
-0.930 (-12.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,009,874
Open
7.770
Bid (Size)
6.370 (1)
Ask (Size)
6.380 (42)
Prev. Close
7.320
Today's Range
6.020 - 8.280
52wk Range
1.090 - 11.18
Shares Outstanding
2,172,309
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Snowflake, GeoVax, Zoom, Target, Tesla: Why These 5 Stocks Are On Investors' Radars Today
August 21, 2024
On Wednesday, major U.S. indices were positive, with the Dow Jones Industrial Average rising 0.1% to 40,890.49.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
August 21, 2024
GeoVax Labs shares popped ahead of the close on Wednesday and continue to bounce around in extended trading following a report suggesting Wayne County confirmed its first case of mpox since 2022.
Via
Benzinga
Performance
YTD
+15.14%
+15.14%
1 Month
+147.67%
+147.67%
3 Month
+292.02%
+292.02%
6 Month
+170.76%
+170.76%
1 Year
-23.93%
-23.93%
More News
Read More
BioMedNewsBreaks — GeoVax Labs Inc. (NASDAQ: GOVX) Enters $8.5M Registered Direct Offering with Institutional Investor
August 21, 2024
Via
Investor Brand Network
Exposures
COVID-19
Registration is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Labs CEO
August 21, 2024
Via
NewMediaWire
GeoVax (GOVX) Stock Pops Ahead of July 18 Catalyst
July 16, 2024
Via
InvestorPlace
GeoVax Stock Is Tumbling Tuesday: What's Going On?
August 20, 2024
Via
Benzinga
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
August 20, 2024
Via
MarketBeat
Exposures
COVID-19
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
August 20, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 20, 2024
Via
Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Virax Biolabs Shares Climb With Mpox Cases: What To Know
August 19, 2024
Via
Benzinga
GeoVax Labs Stock Continues To Surge: What's Going On?
August 19, 2024
Via
Benzinga
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
August 19, 2024
Via
Benzinga
Why Are GeoVax Shares Trading Higher Today?
August 16, 2024
Via
Benzinga
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
August 15, 2024
Via
Benzinga
GeoVax to Present at the Emerging Growth Conference on August 21, 2024
August 15, 2024
Via
NewMediaWire
Exposures
COVID-19
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
August 14, 2024
Via
Benzinga
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
August 14, 2024
Via
Benzinga
GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
August 08, 2024
Via
NewMediaWire
Exposures
COVID-19
GOVX Stock Earnings: Geovax Labs Beats EPS for Q2 2024
August 06, 2024
Via
InvestorPlace
GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
Via
NewMediaWire
Exposures
COVID-19
Update: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
July 31, 2024
Via
NewMediaWire
GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
July 31, 2024
Via
NewMediaWire
GeoVax to Report Second Quarter 2024 Financial Results and Provide Corporate Update on August 6, 2024
July 30, 2024
Via
NewMediaWire
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
July 16, 2024
Via
NewMediaWire
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.